SecBot SecBot

UPC

Universe Pharmaceuticals INC
Nasdaq· Pharmaceutical Preparations· Inc. F4· CIK 0001809616 Biotech & Drug Discovery
$1.48 −0.03 (−1.99%)
Nov 16 4:00 PM ET · prev $1.51
Market cap
$7.7M
Nano cap
1 year
−59.5%
from $3.65 · Nov 17
30 days
−60.6%
from $3.76
52-week range
$1.39–12.18
−88% from high · low Nov 6
Avg volume 20D
188.6K
Oct 29 spike 972.4K
Short interest
41.9K
≈0.8% of shares · +38.4%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 2 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 2/2

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q3 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersBUILDING

    Short interest +38.4% to 41.9K shares. 1.0 days to cover, ≈0.8% of shares.

  • TrendDOWNTREND

    58% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGNEAR_EXIT1,550$6.7K

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 13, 2026 SEC
The SEC declared effective Universe Pharmaceuticals' F-3 shelf registration (File No. 333-299191) on October 9, 2026…
EFFECT · Impact 5/10
Oct 6, 2026 SEC
Universe Pharmaceuticals reported the results of its 2026 Annual General Meeting held on September 30, 2026, where all…
6-K · Impact 5/10
Sep 30, 2026 Inst.
UBS Group AG · NEAR_EXIT
1,550 shares ($6.7K)
Sep 2, 2026 Trading halt
Halt Resumed: UPC, trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-02T13:34:02.000Z | Resumed 2026-09-02T13:39:02.000Z
Jun 26, 2026 SEC
Universe Pharmaceuticals (UPC) announced a share purchase agreement to acquire 100% of Best Praise International…
6-K · Impact 6/10
May 7, 2026 Insider
Lai Gang was granted 12,610 shares
Chief Executive Officer
May 7, 2026 Insider
Lai Gang was granted 71,890 shares
Chief Executive Officer

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
May 7, 2026
Lai Gang
Chief Executive Officer
May 7, 2026
AWARD12,610 sh
May 7, 2026
Lai Gang
Chief Executive Officer
May 7, 2026
AWARD71,890 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
41,937
shares short
+38.4%
vs prior settlement
1.0
days to cover
≈0.8%
of shares outstanding
Trading halts
Sep 2, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 2, 2026
Trading halt
Halt Resumed: UPC, trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-02T13:34:02.000Z | Resumed 2026-09-02T13:39:02.000Z
Sep 2, 2026
Trading halt
Trading Halt: UPC, LUDP (Volatility Trading Pause)
Universe Pharma Ord A | Market: NASDAQ | Code: LUDP, Volatility Trading Pause
Jul 20, 2026
Earnings date
UPC Q2 2026 Earnings Scheduled, 2026-07-20
Jun 26, 2026
M&A
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a…

SecBot reports

3 filings · 0 bullish · 3 bearish
All UPC filing & press-release reports (3)